Patents
Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
12/2007
12/05/2007CN101081843A 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors
12/05/2007CN100352812C Extracted product from leaves of podocarpus and preparation method and use
12/04/2007US7304168 For tracing/imaging molecular transfer between cellular gap junctions
12/04/2007US7304161 3,5-Dimethyl-benzoic acid N-tert-butyl-N'-(3-hydroxymethyl-5-methyl-2,3-dihydro-benzo[1,4]dioxine-6-carbonyl)-hydrazide; 3,5-Dimethyl-benzoic acid N-(1-tert-butyl-2-cyano-vinyl)-N'-(3-methoxy-2-methylbenzoyl)-hydrazide
12/04/2007US7304090 Using fluorescein; polycystic kidney disease, diarrhea, antiarrhythmia agents, antitumor agents, contraceptice
12/04/2007US7303694 crystals that exhibit low toxicity towards cells such as 4'-(3,4-difluorophenyl)-4-propylbicyclohexyl; methods of analyzing cells using liquid crystals; contacting solution of liquid crystal, and a biomolecule with surface that uniformly orients liquid crystal when biomolecule does not bind receptor
11/2007
11/29/2007WO2007136068A1 Process for producing composition having high polyphenol content
11/29/2007WO2007136051A1 Optical recording material, optical recording medium using the optical recording material, and method for reproducing optical recording medium
11/29/2007WO2007135592A1 Flavonoid dimers and methods of making and using such
11/29/2007US20070276147 Synthesis of Oligomeric Epicatechin- and Catechin-Derived Procyanidins
11/29/2007US20070276139 Substituted Pixyl Protecting Groups for Oligonucleotide Synthesis
11/29/2007US20070276138 Modulators of peroxisome proliferator activated receptors
11/29/2007US20070276032 Use of 8-Prenylnaringenin for Hormone Replacement Therapy
11/29/2007US20070276031 Process for Purifying (-)- 9-Trans-Tetrahydrocannabinol
11/29/2007US20070275106 Hydroxylated polymethoxyflavone compositions
11/29/2007US20070274928 Novel Cyclic Oxygenated Compounds Having Cooling, Fragrance, and Flavor Properties, and Uses Thereof
11/29/2007CA2652617A1 Flavonoid dimers and methods of making and using such
11/28/2007EP1858865A1 Substituted n-sulfonylaminophenylethyl-2-phenoxy acetamide compounds
11/28/2007EP1119639B1 7-alkoxycoumarins as cyp2c9 substrates
11/28/2007CN101077864A Vaccinnium vitis-idaea extract, preparation method and application thereof
11/28/2007CN101077852A Preparation for chemical component of Shenmai injection and application of the same in curing cardio-cerebrovascular disease
11/28/2007CN100351248C Genistein derivatives and their preparation process and use
11/27/2007US7301025 N-(2-(2-(alkyl[carbamoyl, carbonyloxy or ureido]alkyl)pyridinium)-5-(carboxy or sulfo)phenyl-8-((2-(N-alkyl[carbamoyl or ureido]alkyl)pyridinyl) xanthene ligands complexed with a metal or metal-containing moiety; magenta dye with improved heat resistance; hot melts or phase change inks
11/27/2007US7300954 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
11/22/2007WO2007132893A1 Suppressor of expression of mcp-1, and ameliorating agent for inflammatory disease, pharmaceutical, supplement, food, beverage or food additive using the suppressor
11/22/2007WO2007131350A1 Inhibitors of human immunodeficiency virus replication
11/22/2007WO2007041167A3 Process for production of delta-9-tetrahydrocannabinol
11/22/2007US20070270381 Using phosphonium compound; therapy for oxidative stresses
11/22/2007US20070269832 Novel affinity labels
11/22/2007US20070269536 Purified bilberry extract containing a mixture of glycosides of delphinidin, cyanidin, petunidin, peonidin, and malvidin; no added bisulfite ions; nutraceuticals and pharmaceuticals
11/22/2007CA2650798A1 Inhibitors of human immunodeficiency virus replication
11/21/2007EP1857443A2 Therapeutic morpholino-substituted compounds
11/21/2007EP1857105A2 Cathartic composition
11/21/2007EP1857104A1 Use of cinnamoyl compound
11/21/2007EP1856085A1 Flavonoid compounds and uses thereof
11/21/2007EP1856084A1 Chromen-4-one derivatives
11/21/2007EP1856083A2 Chromen-4-one inhibitors of anti-apoptotic bcl-2 family members and the uses thereof
11/21/2007EP1856075A1 Substituted arylamine compounds and their use as 5-ht6 modulators
11/21/2007EP1856074A2 Substituted aryl or heteroarylsulfonylbutanamides for use as anti-inflammatory agents
11/21/2007EP1856040A2 Novel lipoxygenase inhibitors
11/21/2007EP1856032A1 Heterocyclic-substituted alkanamides useful as renin inhibitors
11/21/2007EP1455777B1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
11/21/2007EP1315485B1 Cathartic composition
11/21/2007CN101076524A Bicyclic compounds as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
11/21/2007CN101076329A Methods for purifying trans-(-)-delta;9-tetrahydrocannabinol and trans-(+)-delta;9-tetrahydrocannabinol
11/21/2007CN101074258A Method for separating and extracting phytosterin and Vitamin E from soyabean deodorization distillate
11/21/2007CN101074224A Production of high-content EGCG
11/21/2007CN101074223A Versulin derivative and its use in treatment of diabetes and its complication
11/21/2007CN101074222A 3-substituted cumarin compound, its production, medicinal composition and use
11/20/2007US7297820 Thio substituted stilbene amines; inhibiting the aggregation of amyloid proteins
11/20/2007US7297801 Process for the production of 2-oxa-3-one androstane derivatives
11/20/2007US7297715 PPAR alpha selective compounds for the treatment of dyslipidemia and other lipid disorders
11/15/2007WO2007130898A1 TETRASUBSTITUTED UREAS AS MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1
11/15/2007US20070265449 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
11/15/2007US20070265233 Arginine Heteromers for Topical Administration
11/15/2007CA2649677A1 Tetrasubstituted ureas as modulators of 11-.beta. hydroxyl steroid dehydrogenase type 1
11/14/2007EP1853578A1 Substituted tetralins as selective estrogen receptor-beta agonists
11/14/2007EP1562929B1 Manufacture of tocopheryl acetate
11/14/2007EP1368048B1 Pharmaceutical composition made of cannabis extracts
11/14/2007CN101072765A Phenylpiperazines with a combination of affinity for dopamine -D2 receptors and serotonin reuptake sites
11/14/2007CN101072764A (-)-epigallocatechin gallate derivatives for inhibiting proteasome
11/14/2007CN101070309A Substituted piperazines (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
11/14/2007CN101069707A Herba polygonic avicularis total flavones and its preparing method and medicine use
11/14/2007CN100348592C 3,7,8-trisubstituted-5-hydrobenzo-gamma-pyranone compound and its preparation method
11/14/2007CN100348569C Induction of apoptosis in cancer cells
11/13/2007US7294642 1,3-Diamino-2-hydroxypropane pro-drug derivatives
11/13/2007CA2410673C Indolinospiropyran compounds and methods for their manufacture
11/13/2007CA2258243C 4,7-dichlororhodamine dyes
11/13/2007CA2248304C Surface modified carbonate materials
11/13/2007CA2213080C 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
11/08/2007WO2007124617A1 Coumarin derivatives, their preparation methods and their pharmaceutic compositions and uses
11/08/2007WO2006095263A8 Substituted n-sulfonylaminophenylethyl-2-phenoxy acetamide compounds
11/08/2007US20070260025 [Dimethylsilanediyl(2-methyl-8-phenylbenzo[b]cyclopenta[d]-thien-3-ylidene)2]zirconium(IV) dichloride; for homo- and copolymerization of propylene; useful for producing hard and stiff shaped bodies having high ultimate tensile strength, e.g. fibers, filaments, injection-molded parts, films, plates
11/08/2007US20070259950 Nebivolol and Its Pharmaceutically Acceptable Salts, Process for Preparation and Pharmaceutical Compositions of Nebivolol
11/08/2007US20070259944 Amides such as 5-(3-Nitrophenyl)-1,3-dihydro-indol-2-one, used as antiprogesterones, contraceptives, for hormone replacement therapy during menopause and as anticarcinogenic agents
11/07/2007EP1852430A1 Method of producing proanthocyanidin oligomer
11/07/2007EP1852422A2 Nitrosated and nitorsylated alpha-andrenergic receptor antagonist compounds, compositions and their uses
11/07/2007CN101068801A Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
11/07/2007CN101068772A N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
11/07/2007CN101066986A Process of extracting flavone from side product of orange processing
11/07/2007CN101066963A Polysubstituted flavanone derivative and its prepn and application
11/07/2007CN101066962A Synthetic methods for polyphenols
11/07/2007CN101066961A Flavone derivative and its prepn and use
11/07/2007CN101066960A Production process of extracting isoflavone from fern
11/07/2007CN101066959A Simulated four-area moving bed chromatographic process for separating and purifying aloe flavone
11/07/2007CN101066958A Simulated moving-bed chromatographic process for separating and purifying flavone from Chinese yam
11/06/2007USRE39916 Compounds that modulate PPAR activity and methods for their preparation
11/06/2007US7291732 Isomeric fused pyrrolocarbazoles and isoindolones
11/06/2007CA2241666C Tricyclic compounds, their production and use
11/01/2007WO2007123941A2 Chromane and chromene derivatives and uses thereof
11/01/2007WO2007122981A1 COUMARIN COMPOUND CAPABLE OF INHIBITING INDUCIBLE NITROGEN MONOOXIDE SYNTHASE (iNOS)
11/01/2007WO2007053757A3 Flavanols and b-type procyanidins and inflammation
11/01/2007US20070254946 Hair Growth Stimulants
11/01/2007US20070254354 Production of Isoprenoids
11/01/2007US20070254298 Atropisomers of asymmetric xanthene fluorescent dyes and method of dna sequencing and fragment analysis
11/01/2007CA2648894A1 Chromane and chromene derivatives and uses thereof
10/2007
10/31/2007EP1849779A1 Esterified catechin, process for producing the same, food and drink or cosmetic containing the same
10/31/2007EP1848708A1 Sulfamate and sulfamide derivatives for the treatment of epilepsy and related disorders
10/31/2007EP1848424A2 Pharmaceutical composition comprising hydroxylated nebivolol
10/31/2007EP1620421A4 Insecticidal (dihalopropenyl) phenylalkyl substituted dihydrobenzofuran and dihydrobenzopyran derivatives
1 ... 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 ... 242